Cargando…

Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas

Schwannomas are benign neoplasms that can cause gain‐ and loss‐of‐function neurological phenotypes, including severe, intractable pain. To investigate the molecular mechanisms underlying schwannoma‐associated pain we compared the RNA sequencing profile of painful and non‐painful schwannomas from NF2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kukutla, Phanidhar, Ahmed, Sherif G., DuBreuil, Daniel M., Abdelnabi, Ahmed, Cetinbas, Murat, Fulci, Giulia, Aldikacti, Berent, Stemmer‐Rachamimov, Anat, Plotkin, Scott R., Wainger, Brian, Sadreyev, Ruslan I., Brenner, Gary J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Brief Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283170/ https://www.ncbi.nlm.nih.gov/pubmed/34053190 http://dx.doi.org/10.1002/acn3.51386

Ejemplares similares

Comparative Transcriptomic Analysis of Archival Human Vestibular Schwannoma Tissue from Patients with and without Tinnitus
por: Bommakanti, Krishna, et al.
Publicado: (2023)

Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2
por: Prabhakar, Shilpa, et al.
Publicado: (2022)

An update on the CNS manifestations of neurofibromatosis type 2
por: Coy, Shannon, et al.
Publicado: (2019)

Correction to: An update on the CNS manifestations of neurofibromatosis type 2
por: Coy, Shannon, et al.
Publicado: (2019)

Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2
por: Stivaros, Stavros M, et al.
Publicado: (2015)

Segmental neurofibromatosis with deep schwannoma
por: Smith, Wallace A., et al.
Publicado: (2016)

Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2
por: Jordan, Justin T, et al.
Publicado: (2023)

Genome-wide analysis identifies cis-acting elements regulating mRNA polyadenylation and translation during vertebrate oocyte maturation
por: Yang, Fei, et al.
Publicado: (2020)

Long-term dysbiosis and fluctuations of gut microbiome in antibiotic treated preterm infants
por: Cetinbas, Murat, et al.
Publicado: (2023)

Distinct functions of tissue-resident and circulating memory Th2 cells in allergic airway disease
por: Rahimi, Rod A., et al.
Publicado: (2020)

Dynamic Gut Microbiome across Life History of the Malaria Mosquito Anopheles gambiae in Kenya
por: Wang, Ying, et al.
Publicado: (2011)

The waaL gene mutation compromised the inhabitation of Enterobacter sp. Ag1 in the mosquito gut environment
por: Pei, Dong, et al.
Publicado: (2015)

Aryl hydrocarbon receptor and Krüppel like factor 10 mediate a transcriptional axis modulating immune homeostasis in mosquitoes
por: Kulkarni, Aditi, et al.
Publicado: (2022)

New developments in neurofibromatosis type 2 and vestibular schwannoma
por: Ren, Yin, et al.
Publicado: (2020)

Decreased Vision and Junctional Scotoma from Pituicytoma
por: Huynh, Nancy, et al.
Publicado: (2012)

Human gut derived-organoids provide model to study gluten response and effects of microbiota-derived molecules in celiac disease
por: Freire, Rachel, et al.
Publicado: (2019)

Loss of muscleblind splicing factor shortens Caenorhabditis elegans lifespan by reducing the activity of p38 MAPK/PMK-1 and transcription factors ATF-7 and Nrf/SKN-1
por: Matilainen, Olli, et al.
Publicado: (2021)

Insights from the Genome Annotation of Elizabethkingia anophelis from the Malaria Vector Anopheles gambiae
por: Kukutla, Phanidhar, et al.
Publicado: (2014)

Draft Genome Sequences of Elizabethkingia anophelis Strains R26(T) and Ag1 from the Midgut of the Malaria Mosquito Anopheles gambiae
por: Kukutla, Phanidhar, et al.
Publicado: (2013)

Exploiting the Zonulin Mouse Model to Establish the Role of Primary Impaired Gut Barrier Function on Microbiota Composition and Immune Profiles
por: Miranda-Ribera, Alba, et al.
Publicado: (2019)

Neurofibromatosis 2011: a report of the Children’s Tumor Foundation Annual Meeting
por: Kalamarides, Michel, et al.
Publicado: (2011)

Long-Term Outcomes of Stereotactic Radiosurgery for Vestibular Schwannoma Associated with Neurofibromatosis Type 2 in Comparison to Sporadic Schwannoma
por: Shinya, Yuki, et al.
Publicado: (2019)

A rare retroperitoneal schwannoma in a patient with neurofibromatosis Type 2
por: Patrinou, Alexandra, et al.
Publicado: (2010)

A Bilateral Vestibular Schwannoma is Not Always Related to Neurofibromatosis Type 2
por: Abeshi, Andi, et al.
Publicado: (2023)

Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene
por: Miller, Shyra J, et al.
Publicado: (2009)

Model-based identification of conditionally-essential genes from transposon-insertion sequencing data
por: Sarsani, Vishal, et al.
Publicado: (2022)

A high-content platform for physiological profiling and unbiased classification of individual neurons
por: DuBreuil, Daniel M., et al.
Publicado: (2021)

Spontaneous rupture of an arachnoid cyst in an adult: illustrative case
por: Leavitt, Lydia A., et al.
Publicado: (2023)

A case report of giant malignant schwannoma of the sciatic nerve associated with neurofibromatosis-1: A CARE-compliant article
por: Gokkus, Kemal, et al.
Publicado: (2023)

Bevacizumab Treatment for Meningiomas in NF2: A Retrospective Analysis of 15 Patients
por: Nunes, Fabio P., et al.
Publicado: (2013)

Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
por: Legius, Eric, et al.
Publicado: (2021)

Awareness and agreement with neurofibromatosis care guidelines among U.S. neurofibromatosis specialists
por: Merker, Vanessa L., et al.
Publicado: (2022)

The impact of stereotactic radiosurgery in the management of neurofibromatosis type 2-related vestibular schwannomas
por: Lustgarten, Leonardo
Publicado: (2013)

Multiple bilateral cranial nerve schwannomas in a patient with neurofibromatosis type 2
por: Pasricha, Ribhav, et al.
Publicado: (2016)

Bevacizumab Therapy of Neurofibromatosis Type 2 Associated Vestibular Schwannoma in Japanese Patients
por: FUJII, Masazumi, et al.
Publicado: (2020)

Tumors displaying hybrid schwannoma and neurofibroma features in patients with neurofibromatosis type 2
por: Montgomery, Blake K., et al.
Publicado: (2016)

Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis
por: Bachir, Suha, et al.
Publicado: (2021)

Genomic profiling distinguishes familial multiple and sporadic multiple meningiomas
por: Shen, Yiping, et al.
Publicado: (2009)

COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis
por: Banerjee, Jineta, et al.
Publicado: (2023)

Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1
por: Isakson, Sara H., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_n3o352t6npdg8ubbstvj86hprk